BACKGROUND Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) transmitted by mosquitoes. The potential for ZIKV transmission through blood transfusion was demonstrated during the ZIKV outbreak that occurred in French Polynesia from October 2013 to April 2014. Pathogen inactivation of blood products is a proactive strategy that provides the potential to reduce transfusion-transmitted dise...

INTRODUCTION Hepatitis B and C are among the most important transfusion-transmitted infections and sources of liver diseases worldwide. In Veracruz, Mexico, liver diseases are important causes of mortality, and the prevalence reports of these viruses are scarce. This study sought to determine the prevalence of these infections in blood donors, in order to increase the safety of blood products i...

Introduction: Transfusion-transmitted infections continue to be a threat the safety of blood supply, in particular risk is high for parenterally transmitted viral hepatitis pediatric malignancy. The aim was estimate prevalence children with malignancy, identify some variables that could affect these patients, and have an idea about effect vaccination controlling infection. Method: A Cross secti...

BACKGROUND Virus inactivation of plasma intended for transfusion avoids the transmission of hepatitis B virus, hepatitis C virus, and HIV. However, because most plasma recipients also receive other blood components concomitantly, the procedure reduces but cannot eliminate the risk of transfusion-transmitted infection. As virus-inactivated plasma has just been licensed in the United States and o...